University of Kentucky

UKnowledge
Pediatrics Faculty Publications

Pediatrics

2012

The Adolescent Breast
Donald E. Greydanus
Michigan State University

Stephanie Stockburger
University of Kentucky, stephanie.stockburger@uky.edu

Hatim A. Omar
University of Kentucky, hatim.omar@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/pediatrics_facpub
Part of the Pediatrics Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Greydanus, Donald E.; Stockburger, Stephanie; and Omar, Hatim A., "The Adolescent Breast" (2012).
Pediatrics Faculty Publications. 103.
https://uknowledge.uky.edu/pediatrics_facpub/103

This Book Chapter is brought to you for free and open access by the Pediatrics at UKnowledge. It has been
accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of UKnowledge. For more
information, please contact UKnowledge@lsv.uky.edu.

The Adolescent Breast
Notes/Citation Information
Published in Adolescent Medicine: Pharmacotherapeutics in General, Mental and Sexual Health. Donald E.
Greydanus, Dilip R. Patel, Hatim A. Omar, Cynthia Feucht, & Joav Merrick, (Eds.). p. 285-299.
©2012 Walter de Greyter GmbH & Co. KG, Berlin, Boston
The copyright holder has granted permission for posting the chapter here.
Reprinted as an article in International Journal of Child and Adolescent Health, v. 5, no. 4, p. 345-355.
Reprinted as a book chapter in Child and Adolescent Health Yearbook 2012. Joav Merrick, (Ed.). p.
399-414.

This book chapter is available at UKnowledge: https://uknowledge.uky.edu/pediatrics_facpub/103

adolescent breast
ld E. Creydanus, Stephanie Stockburger, and Hatim A. Omar

is an important organ system for the adolescent female and occasionally for
lescent male as well. This chapter reviews basic principles of breast concerns
ers including congenital anomalies, asymmetric breast development, underbreasts, virginal hypertrophy, breast masses, mastaglia, galactorrhea, gynea in males, and others. Clinicians should be attuned to issues and concerns for
structure in adolescents.

is a modified sweat gland that is enveloped by layers (superficial and deep)
rficial fascia in the thorax; this organ system is suspended from the chest wall
s ligaments (fibrous septae) that extend from the pectoralis fascia to the derprogesterone, and prolactin are hormones that are important in breast
ent as reviewed in ~Tab. 16.1. Additional key hormones include thyroxine,
growth hormone, and adrenal corticoids.

inician's breast examination
often neglected by clinicians, breast examination remains an important aspect
·cal examination process in adolescents (1,2,3,4,5). Though rare in adolespain and/or a breast lump stimulate fears of breast cancer in the youth
parents. The clinician should not ignore this system, but learn to minimize
nt in the exam process and help the adolescent understand her body as
ble. During the adolescent years, she can be taught about breast selfas a way of reducing her breast cancer risk as she reaches adulthood.
"'"''T-"''r"minations should be developed by age 20 years.
history is important and includes asking about age, when the breast buds
(Tanner 2 or sexual maturity rating 2) and breast growth rate as well as
presence of nipple discharge, lesions, and pain. A menstrual history is
nt to obtain. The female may be concerned about the size of her breasts,
mmetry, or the timing of the growth of her breasts (precocious or delayed).
youth may not vocalize concerns, it is important to emphasize the normalcy
if appropriate.
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Tab. 16.1: Impact of hormones on breast develoment.
1. Estrogen induces the following:
a. Ductal system growth
b. Nipple maturation
c. Areolar development (increased pigmentation and size)
d. Induction of periductal fibrous tissue growth
2. Progesterone induces alveolar maturation.
3. Prolactin allows maturation resulting in lactation .

16.3 Congenital anomalies
16.3.1 Athelia and amastia
The absence of a nipple (athelia) is a rare congenital anomaly resulting from the i
taking exogenous androgen during pregnancy (6,7). Another rare anomaly is absence
breast (amastia), caused by mammary ridge involution involving the pectoral ridge on
affected side. Amastia is typically unilateral and in association with defects of the
wall. Poland syndrome is characterized by unilateral amastia with no pectoralis mu
development, defects of the ribs, radial nerve palsy, and webbing of the fingers.
can be acquired after birth from inadvertent breast bed biopsy, radiation damage to
breast, or other injury. Treatment involves surgical correction of abnormalities.

16.3.2 Polythelia and polymastia
Extra accessory nipples (polythelia) and accessory breast tissue (polymastia or supe
merary breasts) are more common congenital breast anomalies found along the m
lines from the axilla to the groin. A variety of nipple, areola, and glandular tissue
binations can be found. Polythelia (involving nipple and areola) is noted in 1- 2
of the general population and may be associated with cardiovascular and genitouri
defects. The extra nipple tissue may erroneously be called a mole, while the
breast tissue can be mistaken for hidradenitis suppurativa. Management involves su
cal removal if the patient is concerned about cosmetic appearance.

16.3.3 Other nipple anomalies
A nipple that does not extend beyond the breast surface is called an inverted ni
often bilateral and normally corrects itself within a few weeks after birth. If still
after puberty, concerns about its appearance, frequent infection, and/or lactation
lems may surface in the youth . Congenital nipple inversion can lead to chronic a
abscess, characterized by nipple swelling, pain, and discharge along with peria
erythema. Treatment involves local heat, antibiotics, and surgery in some cases
remove the duct system.
Acute retraction of a nipple may suggest breast disease, such as breast cancer.
tunately, this is rare in the adolescent. Other defects include a depressed nipple
lactiferous ducts opening into a depressed area in the areolar center) and a bifid or
nipple. Depressed, bifid, or split nipple may also be managed surgically.

16.4 Asymmetric breast development
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Asymmetric breast development
asymmetry develops in many female adolescents, often improves as puberty
and is noted in about 25 percent of adult females (8). It usually is a normal
iant of breast growth with the smaller breast typically opposite to the dominant
nd. A padded bra and reassurance is all that is needed in most cases. Once the breast
lopment is complete on both sides, surgical correction of the asymmetry can be
nsidered if desired and affordable.
In adolescence, as one breast bud develops before the other, the young adolescent
present with a unilateral mass sometimes mistaken for a tumor. Biopsy of this
results in damage to the yet-to-mature breast and should be avoided. Damage
a breast bud can also result from injury to this area from infection, burns, anterolatthoracotomy, and thoracostomy tube insertions in childhood. Burns to the chest
usually cause skin contractu res with underlying breast tissue that is normal; release
these contractures in the early teen years allow normal growth of the adolescent
Also, scoliosis or defects of the rib cage can result in the appearance of breast
metry, or pseudoasymmetry.

Underdeveloped breasts
mon concern among adolescent females is that of small breasts (micromastia), or
that are much smaller than what they or society feels are normal. It is often a
ilial condition and may be noted in those with a tall, thin body type with limited
utaneous tissue in general and sometimes who have connective tissue disorders.
urance of the normalcy of the breasts is important and that the "small" breasts
not interfere with her sense of femininity, sexual relations, pregnancy, or lacta. Augmentation mammoplasty can be done at some time in her life when she is
ionally, cognitively, and financially ready for such surgery.
nilateral or bilateral hypoplasia of the breasts may be difficult to distinguish from
cromastia. Hypoplasia or hypomastia may be due to partial end-organ response failin which the breast(s) do not develop into normal breasts. Bilateral hypoplasia may
It from androgen excess in utero or in early infant life; this may be due to congenital
nal hyperplasia, leading to the prevention of ovarian maturation and estrogen
retion during puberty. The nipples are smaller, less pigmented, less estrogenized,
do not have papillae that are protuberant. The public hair may develop without
arche, and menarche may be delayed. A careful genetic and endocrinologic evalon is necessary for bilateral hypoplasia. Causes include gonadal dysgenesis (Turner
rome), androgen-producing tumor, preadolescent hypothyroidism, and gonadotrodeficiency (pituitary hypogonadism). Poor or limited breast development may also
It from radiation and bilateral ovariectomy.

of the breasts results from significant weight loss and hypoestrogenemia, as
in anorexia nervosa, chronic illness, postpartum depression, crash dieting, and
conditions. The result is loss of breast adipose tissue and, often, severe acquired
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breast atrophy. Scleroderma can cause local breast changes, while premature
failure can induce secondary amenorrhea and breast atophy. The breasts
wrinkled, flattened, and old in appearance. Treatment of breast atrophy is to
the underlying problem.

16.5.1 Tuberous breasts
In this rare breast anomaly, the shape of the breasts is abnormal in which the
breasts project forward without normal fullness; the areolar complex is overdevel
with the appearance of herniation of breast tissue into the areola. Surgical rn•·rpr·t•
is necessary to improve the breast appearance by reconstructing the nippl
complex along with breast augmentation.

16.6 Virginal hypertrophy
Thelarche in some females leads to massive diffuse enlargement of breasts to s
extent that it is termed juvenile, virginal, or idiopathic breast hypertrophy; even
massive development is called macromastia or gigantomastia (9). The cause is us
linked to individual variation, familial factors, sensitivity to estrogen and/or abno
estrogen-progesterone ratio, and endogenous production of estrogen within
cells. Obesity may play a role in some youth. Unilateral hypertrophy may also
seen and can be caused by a breast neoplasm (such as a giant fibroadenoma section 16.7). Breasts may develop superficial changes including prominent su
ficial veins and possibly skin necrosis. The nipple and areola may be stretch
that they are difficult to distinguish. Complications may be worsened with a
brassiere.
There are no medications that are acceptable to use in adolescents. Some clinici
have used danazol or medroxyprogesterone to reduced brease size; however,
no clear research that these really help. Side effects of the medications (such as m
linization and teratogenicity) prohibit their use in youth. Surgical breast reduction i
option when the adolescent is mature enough to understand this surgery and
potential complications. If surgery is done too early, breast enlargement may
and negate the effects of the surgery. Breast reduction often involves reimplantatio
the nipple-areolar complex, leading to potential lactation and nerve damage; the
potential of breast stimulation may be reduced.

16.7 Breast masses
The following box, "Causes of Breast Masses in Adolescents," lists causes of b
masses in the adolescent; 70-90 percent of masses that are biopsied are fibroadeno
and most of the other masses are benign cysts. Since malignancy is rare in the adol
cent, observation of a mass over a few months is usually an appropriate clin
response. Breast cancer is noted in less than 2.5 percent of palpable breast masses
females under 30 and less than 0.5 percent in those under age 20 years.

16.7 Breast masses
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Important historical points in assessment of a breast mass include if there is assopain (cyclical or noncyclical), galactorrhea, size of the lesion, and how long it
been present. An excisional biopsy is typically obtained for a mass that is hard,
not resolve, increases in size, fails to decrease over a few menstrual cycles,
after aspiration, and or has bloody nipple discharge.

is a benign tumor arising from ducts and stoma of the terminal part of the
system (8). It is the most common lesion noted in postpubertal females up to
5 years of age. Fibroadenomas are typically well demarcated, encapsulated, round, ruband nontender. They are usually single and found in the upper, outer quadrant,
any quadrant may be noted. As many as 20 percent have bilateral or multiple

lhrn::>,n<>lhnlm::>
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tumors, in which case the condition is called fibroadenomatosis. A fibroadenoma

2-3 em when first found but may enlarge at the end of a menstrual cycle and can
increase during pregnancy. The ultrasound appearance is that of a smooth
mass that is homogeneous.
A fibroadenoma does not become malignant and does not increase the ado
risk for malignancy later in life. If a lesion appearing to be a fibroadenoma
decrease over 4 to 6 months, or if it continues to enlarge, excision is usually
mended. Removal of a large mass may require more surgery to reduce the skin
lope for a cosmetic closure. If concern is raised about potential cancer, excisi
also suggested.

Giant (juvenile) fibroadenoma
A fibroadenoma that is more than 5 em is often defined as a giant or juvenile type
important because it can grow quickly to a large size, doubling itself in 3 to 6
tends to be seen in young adolescents, has a consistency that is softer, has more
of superficial veins, and can cause considerable breast distortion. Though a
tumor, it should be excised before becoming too large.

16.7 .1 Cystosarcoma phylloides
Cystosarcoma phylloides (phylloides tumors) is the most common malignant tumor
breast reported in adolescents. Though a rare event in youth, the incidence is 0.
percent of all breast tumors in adults with an incidence of metastasis of 3-12
approximately 8 percent of these tumors occur in females under age 20
Cystosarcoma phylloides presents as a painless, multilobular tumor that is rapidly
ing, nonfixed, and often 8-10 em when first found. It often presents with
discharge, venous dilation, and skin discoloration. Studies note that 10-15
are malignant and metastases develop, particularly to the lungs. A wide exci
2 em margins that are tumor free) is considered curative for benign tumors.
of a malignant type includes surgery, radiation, chemotherapy, and hormonal
Though the prognosis is poor, it is better in adolescents than in adults.

Intraductal papilloma

Intraductal papilloma (papillomatosis) typi ca lly presents as a painful, subareolar
that is unilateral in three-fourths of cases. A serosanguineous or serous nipple d
is often descr ibed on the affected side. In studies of breast masses in ado locr<>nt~ <
incidence of 4 percent to 6 percent and a mean age of 17 to 18 years of age at
tation are reported. In 30 percent of cases, a painful mass is not appreciated,
breast palpation may compress ducts filled with tumor that leads to nipple disch
The differential diagnosis is listed in the following box. The evaluation may i
fine-needle aspiration, breast ultrasonography, and ductography. Intraductal papill
is typically a benign tumor, though the adolescent patient should be followed
for the possible development of a malignant change.

16.7 Breast masses
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ry duct ectasia (periductal mastitis) refers to a condition that presents as a painsubareolar nodule with nipple discharge, nipple retraction, sinus tracts (or fistulae),
d axillary lymphadenopathy. It is usually seen in adult females at menopause who
had a history of lactation problems. It is the most common cause of acquired
le inversion. Infection with Bacteroides sp. is seen in adolescents, leading to
ammatory changes and periductal fibrosis and destruction of the ductal wall.
nt includes local excision of the sinus tract or fistula along with antibiotics.

7.2 Cystic breast disease
I known, but less common in the adolescents are single or multiple cysts of benign
disease. These cysts are typically not fixed to breast tissue, and aspiration reveals
le fluid that is clear, brownish, or blood tinged . Cysts can be classified in various
and one system is listed in the following box, including normal physiological
nges in breast size in adolescents with up to 50 percent size change during a men1cycle; these pseudolumps are normal. In the postpartum period, lactiferous ducts
become distended and become galactoceles, presenting as a subareo lar mass with
low nipple discharge; it usually disappears with lactation, but surgical exc ision
become necessary.

Management of a breast cyst often involves fine-needle aspiration with cytological
luation to identify if it is a matter of normal physiology or overt pathology. If the
on disappears on aspiration, it is assumed to be a cyst, and the patient can be evalagain in 2 to 3 months. It the lesion recurs or is solid, ultrasonography is obtained
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for further evaluation . Sometimes an open, exisional biopsy is necessary to
and remove the breast lesion, if aspiration is not successful or not possible.
16.7 .3 Fibrocystic change

Fibrocystic change (previously called fibrocystic disease) is noted in adolescents
more commonly seen in adult females over age 35 years. It presents as firm, m
nodularities that are cord-like and distributed diffusely in the breasts. Some
develop " lumpy" breasts in their young adult years that may develop into
cystic change in later adult life. Typically, there is breast tenderness before
tion and 'change in breast size during the menstrual cycle. Sometimes,
pain and size change may be noted. Biopsy may be necessary to identify the
pathology.
Management includes good brassiere support and heat. Ibuprofen may be hel
adolescents. Oral contraceptives may offer pain relief by inhibiting progesterone
tion, as cysts tend to be more painful in the secretory or progestational part of the
strual cycle. Though recommended by some clinicians, there is no clear
support for the use of vitamine E, alpha-tocopherol (600 IU/day), and dietary lim
of methylxanthines (caffeine and other substances). Danazol, bromocriptine,
tamoxifen have been tried in adults but have no clear indication in adolescents.

Breast abscess
A breast abscess presents as a painful, cystic les io n with erythema that is raised
often indurated; there may also be mastitis (1 0) . One or multiple abscess
noted along with fever, cellulitis, and regional lymphadenopathy. Causes of
abscess include squeezing acne les ions, areolar hair plucking, lactation, trauma
eluding sexual), epidermal cyst, and chronic illness with reduced host defenses.
most common bacterial causes include Staphylococcus aureus and Strep
thou gh Escherichia coliPseudomonas, and other gram-negative organisms ha
been noted. Blood cu ltures should be obtained in hospitalized patients.
Management includes heat with warm compresses, analgesics, incision, and d
age. Antibiotics are given seeking to cover most likely organisms and often inc
amoxicillin-clavulanate potassium or various cephalosporins. Antibiotic regi
should provide antistaphylococcal coverage. In more severe infections, an
should be given parenterally. There is a 50 percent recurrence rate for i
are delayed or only partially treated. Residual scarring may develop if there is un
ing trauma and be mistaken for a tumor. A subareolar abscess can result in scarring
leads to an inverted nipple. If lactatio nal mastitis develops, breast feeding is usually
stopped unless overt purulent nippl e discharge develops.

Mastodynia
Mastodynia (mastalgia) refers to breast pain, often a hormonally induced process
cyclical and associated with physiological changes characterized by nodularities
swellings. Menstrually induced mastodynia may be due to deficient activity of the
pus luteum produci ng a relative hyperestronism . Breast trauma (the adolescent

16.8 Nipple discharge
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have forgotten an inciting incident), hypertrophy, and infection can cause breast
Breast pain may also be a side effect of oral contraceptives. Other medications
can induce painful breast enlargement include phenothiazines, resperpine, exoghormones, and possibly, marijuana. The differential diagnosis of mastodynia
costochondritis, cardiac disease, and cervical spine pathology.
agement of mastodynia includes heat, good bra support, and analgesics (includthe nonsteroidal anti-inflammatory agents ibuprofen or naproxen sodium) (11 ). If
nous estrogen is an underlying cause, stop this medication. If the pain is severe
not related to estrogen administration, cycling the menstrual periods with oral con'ves may be helpful. Some clinicians prescribe vitamine E (alpha-tocopherol),
h actual benefit in this situation is not proved. Other unproven measures used
adult females with mastodynia are evening primrose oil and the avoidance of
nthines (found in cola, tea, or coffee), chocolate, nicotine, stress, and dairy
I pharmacotherapeutics include danazol, bromocriptine, and tamoxifen.
is an androgen steroid and used by some clinicians to manage severe breast
n in adult females; it is not recommended in adolescents because it is not proved
help. Danazol has significant side effects, such as potential masculinization and terncity. Also tried in adult females are bromocriptine (a prolactin antagonist) and
(competes for estrogen receptors); there is no evidence of their benefit in
lescents. If breast discomfort or pain is part of swelling and weight gain associated
th the menstrual cycle, diuretics may help with the breast swelling and pain.
Mondor's disease is superficial thrombophlebitis of the thoracoepigastric vein seen
pregnancy and various types of trauma (including biopsy or breast surgery). It prewith painful cords of phlebitis palpated over the involved breast, typically in the
, lateral breast area. It typically fully resolves in 10 to 21 days, and management
eludes local heat along with oral analgesics.

Nipple discharge
of nipple discharge are listed in the following box (12). A yellow discharge is
with normal physiological effects or a galactocele, while a clear, serous, or greendischarge suggests a physiological cyst. If the discharge is milky, consider such
uses as lactation, breast cancer, microadenoma, elevated thyroid stimulating horone, acromegaly, or phenothiazine effects. A bloody nipple discharge may be due
cystosarcoma phylloides, papillary carcinoma, intraductal papilloma, or cystic duehyperplasia. A brownish nipple discharge is noted with Montgomery gland secretion
intraductal papilloma, while a purulent discharge is associated with infection.
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When evaluating an adolescent with a nipple discharge, the clinician should
careful history that includes the amount and color of the nipple discharge, associated
abnormalities, and any history for trauma, breast manipulation, or menstrual
Examine the breasts (including the nipples) carefully. A ductogram (galactograph)
be helpful. Surgery may be necessary to remove the involved areolar duct to be
rare malignancy is not present, such as cytosarcoma phylloides or papillary

Galactorrhea
Galactorrhea is breast milk secretion unrelated to pregnancy or nursing that
more than 1 year after nursing. The fluid may be clear, white or milky, green, or
it varies in amount, and a Sudan stain reveals fat globules. IJi>- Tab. 16.2 lists
Tab. 16.2: Causes of galactorrhea.
Recent pregnancy terminated by spontaneous or induced abortion
Neurogenic
Chest wall disorders
Bronchiectasis and chronic bronchitis
Herpes zoster
Chronic crutch use
Thoracotomy or thoracoplasty
Burns to chest wall
Breast (nipple) manipulation or stimulation
Chronic inflammatory disease or abscess of breast
Psychogenic, including pseudocyesis and pseudonursing
Miscellaneous
Hysterectomy or uterine tumors
Laparotomy
Spinal cord disorders and surgery
Idiopathic normoprolactinemic, with or without amenorrhea
Central nervous system abnormalities
Diffuse brain disease
Coma
Pseudotumor cerebri
Encephalitis and sequelae
Uremia
Tumors, infiltrations, structural abnormalities
Neurocutaneous syndromes
Craniopharyngioma

16.8 Nipple discharge
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Cau ses of galactorrhea. (Continued)

B:PPineal tumors
()ther intrac rani al tumors, cysts, an d masses
,, Histiocytosis X
Sarcoidosi s
Pituitary
Stalk section
, Empty sella syndrome
Pituitary infarction and Sheehan syndrome
Hyperprolactinemi a with or without pro lactinoma
''Other functional pituitary tumors
Hypo- and hyperthyroidism
Chronic renal disease
Adrenal tumors and hypernephrom as
Cirrhosis
Nelson syndrome
Acute intermittent porphyria
Testicular and ovarian tumors
Contraceptive pill s, including other estrogen or progesterone
Polycystic ovary syndrome
Starvation or refeed ing (includin g anorexia nervosa)
Cushing's d isease
Hypogonadism

c

Drugs
• Phenothi azines, thioxa nthines, other major tranquili zers
• Tricyclic antidepressants
• Opiates, including codeine and heroin
• Monoamine oxidase inhibitors
• Amphetamines
• Chlordi azepoxide
• Meprobamate
• Metoclopramide
• Bromocriptine withdrawal
• Cimetidine and ranitidine
• Tamoxifen
• Verapamil
• Isoniazid
• Estrogens
• Oth~r psychotropic drugs
• Other chemotherapy drugs (cisplatin, cytosine arabinoside, adriamycin)
Reprinted, with permission from : Greydanus DE, Shearin RB . Adolescent sexuality and gynecology.
Philade lphi a: Lea & Febiger, 1990:145.
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galactorrhea, though the most frequent are idiopathic (benign), self-manipulation,
macological, prolactinoma, and hypothyroidism. A variety of medications or
induce hyperprolactinemia, including those that block dopamine receptors
antidepressants, butyrophenones, and phenothiazines), deplete dopamine (as
stimulate lactotrophs (narcotics, verapamil, and high dose estrogens), and
dopamine receptors in the gastrointestinal tract (metoclopramide). Galactorrh
be induced by oral contraceptives, reserpine, spironolactone,
and others. M ar ijuana has been implicated but is not proved as a cause.
The adolescent who presents with galactorrhea needs a careful evaluation
many causes that are possible, as noted in ~Tab. 16.2. The history should
drug abuse, menstrual abnormality, breast stimulation, headaches, visual di
thyroid disorder, and other factors. Depending on history and physical exam,
prolactin and thyroid levels is prudent. ACT or MRI of the sella turcica may be i
tests to obtain. Additional testing may be necessary depending on the precise find
The management depends on the underlying etiology. Underlying thyroid
tion or menstrual abnormality should be treated. Management of a microade
often with a dopamine agonist, as bromocriptine, and if necessary, surgery.
drugs or med ications should be stopped, as should be self-manipulation or stimu
if causative. Careful follow-up is important, and consultation with experts is
for severe, confusing, or cases resistant to treatment.
Gynecomastia

Gynecomastia is a proliferation of the glandular tissue of the male breast and
neonatal, prepubertal, or pubertal. Transient breast development is noted in
cent of adolescent males and may be linked to transient imbalances in endogenous
duction of estrogen (relative excess) and testosterone (relative deficiency) with end
sensitivity. Th e most common type consists of a small, tender, firm, discoid su
mass measuring 2 to 3 em in diameter, which is referred to as type 1
benign adolescent hypertrophy. Type 2 gynecomastia is a more generalized
enlargement approx imating Tanner stage 3 or even stage 4 breast development
adolescent girls.
Besides idiopathic gynecomastia, pseudogynecomastia may occur in obese
males with the deposition offat in the breast region or in youth with well-devel
toralis muscles. If gynecomastia occurs at a time other than between Tanner 2
pubertal stages, other causes should be considered. Such causes are often
as hypothal amic, pituitary, endocrine (hormonal), or drug induced . Hypogon
as seen in Klinefelter's syndrome, must be ruled out. Klinefelter's syndrome
sent with gynecomastia and small testes. Other pituitary-gonadal endocrinopath
also be implicated, including pituitary, adrenal, or testicular tumors. A wide
drugs have also been implicated includin g estrogens (which may be taken as
drugs by some gay youths) and others Iisted in ~Ta b. 16.3.
A careful evaluation is necessary for youth with gynecomastia. The hi
include drugs/medications, family history, duration of the gynecomastia, weight
and systemic disease symptomatology. The physical examination must include
staging and size of each breast, testicul ar exam, and abdominal and
exams. Height, weight, and vital signs are also important.

16.8 Nipple discharge
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16.3: Causes of gynecomastia.
Familial gynecomastia
. Klinefelter's syndrome
Androgen insensitivity syndrome
Hodgkin's disease
Pituitary tumor
Adrenal tumor
Thyroid dysfunction (hypo/hyperthyroidism)
Miscellaneous tumors (teratoma, seminoma, Leyd ig-cell tumor, hepatoma, bronchogenic
carcinoma, others)
Cirrhosis of the I iver
Chronic glomerulonephritis
. Male pseudohermaphroditism
Leukemia

Traumati c paraplegia
Starvation (on refeeding)

lfan (and other chemotherapeutic agents)

rinted and modified, with permission: Greydanus DE, Shearin RB. Adolescent sexuality
gynecology. Philadelphia: Lea & Febiger, 1990:148.
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Treatment of normal physiological gynecomastia consists, first, of
boy that his hormones have not gone awry and that some mysterious intern
sion has not confused his sex. Mild forms, or stage 1 gynecomastia, require
more. Boys who are singularly upset or bordering on homosexual panic (a not
mon normal developmental stage in the young adolescent that is likely to be
bated by gynecomastia) may need additional counseling, emotional
possibly a medical excuse (based on some other less compromising cause)
ical education classes to avoid the overwhelming anxi ety that may be encou
the locker room .
Any gynecomastia-inducing drug that is being taken should be in<>•nrll·,,r, _·
stopped. Type 2 gynecomastia deserves surgical correction as soon as it is a
that resolution will not occur (that is, after observation for 6 to 12 months).
therapy (as with testosterone, tamoxifen, clomiphene, or danazol) is not
commended for adolescents. Testosterone has been used for the gynecomasti
in Klinefelter' s syndrome, and antiestrogenic medications (tamoxifen and clomi
have been used in some adults with gynecomastia.

16.9 Summary
This chapter has reviewed important issues and disorders in the adolescent b
an organ system with complex ties to sexuality and potential pathology. The
lescent female may present with concerns of having too large or too sm all b
breast pain, breast mass, or other issues as noted in this chapter. Concerns
are raised should be addressed with a comprehensive yet sensitive h ·
physical examination. Pharmacological management is also concerned
appropriate.
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